glp-1/gip dual agonist weight loss GLP-1 Medications for Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 Medications: Everything You Need

Elizabeth Cairns, a reporter at Endpoints News, pointed out that while pills would likely increase adherence, oral drugs are often dosed at higher levels than injections, which means they often come with more side effects

Advantage: Eli Lilly has the advantage of possessing a next-generation drug (tirzepatide) that has demonstrated impressive results, particularly in the obesity space

Research suggests AOD-9604 stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat creation) without affecting blood sugar levels or growth parameters

Longer acting GLP-1 receptor agonists and the potential for improved cardiovascular outcomes: a review of current literature

Thus, the success of Byetta catalyzed a competitive race to create improved GLP-1 drugs

Note: This product alone is not intended to diagnose, treat, cure, or prevent any disease